Clinical Trial Update: Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results for the combination of sitravatinib and nivolumab in patients with advanced or metastatic renal cell carcinoma (including clear cell his…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sitravatinib (sitravatinib)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-19